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Accepted 8 November 2012AbstractObjective: To reveal the exogenous effects of sex hormones on cell proliferation and apoptosis in the detrusor muscle of ovariectomized rat
urinary bladder.
Materials and Methods: Proliferating cell nuclear antigen (PCNA) and in-situ apoptosis detection kit were used to evaluate cell proliferation and
death in the detrusor muscle of castrated female rats after 1 day, 3 days, and 7 days of supplementary sex steroid hormone administration,
including estrogen, progesterone, and testosterone. The percentage of cells positive for PCNA (proliferative index) and for apoptosis (apoptotic
index) in various groups was calculated.
Results: When compared to the group of bilateral ovariectomy without hormonal supplementation, the groups given 3 days and 7 days of
estrogen supplementation ( p ¼ 0.031 and p ¼ 0.005, respectively) and the group given 7 days of combined supplementation with estrogen and
progesterone ( p ¼ 0.044) had a significant increase in the proliferative indices. A significant decrease of apoptotic index was found in the group
given 7 days of estrogen supplementation when compared to bilateral ovariectomy without hormonal supplementation ( p ¼ 0.035).
Conclusions: Exogenous estrogen supplementation stimulates proliferation and slows down apoptosis in the detrusor muscle of ovariectomized
rat urinary bladder, an effect not counteracted by concomitant use of progesterone. Our results may have clinical implications for estrogen
supplementation in offering benefits to menopausal women with lower urinary tract syndromes, based on evaluating the relationship between cell
apoptosis and cell proliferation.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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The tissues of the lower urinary tract and pelvic floor are
known to be estrogen sensitive because estrogen receptors are
located throughout the bladder and urethra [1e3]. Hypo-
estrogenism is known for its relationship with the development
of lower urinary tract syndromes in women, such as urgency,
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http://dx.doi.org/10.1016/j.tjog.2012.11.003[4,5]. In animal studies, hypoestrogenism caused by ovariec-
tomy has been shown to induce urothelial atrophy [6], and
result in significantly decreased smooth muscle density and
increased connective tissue within the detrusor of urinary
bladder [7e9]. Histologically, ovariectomy causes significant
urothelial apoptosis and, with estrogen treatment, there would
be significant urothelial growth and hyperplasia [10]. Hyper-
plasia and apoptosis are opposing cellular processes; subse-
quent estrogen treatment after ovariectomy increases bladder
smooth muscle cell density, possibly owing to proliferation of
smooth muscle cells [3,8], but the details about increased
bladder smooth muscle cells are still vague. However,
expression of the apoptosis in ovariectomized rodent detrusorcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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estrogen, but also progesterone and testosterone have been
reported in potentially exerting certain effects on the lower
urinary tract [11e13]. So, the purpose of the present experi-
ment is to reveal, after ovarian castration, the exogenous ef-
fects of estrogen, progesterone, and testosterone on cell
proliferation and apoptosis of the detrusor muscle.Materials and methods
Thirty mature female SpragueeDawley rats (from the
National Laboratory Animal Center, Taipei, Taiwan) weighing
250e300 g were divided into five experimental groups for
analyzing the cell proliferation and the cell death of detrusor
muscle. Prior to any sex hormone was supplied to experi-
mental groups, bilateral ovariectomy was performed through a
lower abdominal midline incision using sterile technique with
2% isoflurane in oxygen. The animals were allowed to live at
an ambient temperature (21e23 C) after recovery from the
anesthesia. The sex steroid hormones supplementation started
2 weeks after castration in the following fashion: Group 1
received no hormonal supplementation after ovariectomy;
Group 2 received an intramuscular injection of estrogen
(estradiol benzoate, 50 mg/day; Wyeth-Ayerst , Saint Laurent,
Quebec, Canada); Group 3 was given an intramuscular in-
jection of progesterone (medroxyprogesterone acetate, 2 mg/
day; Pharmacia NV, Puurs, Belgium); Group 4 was treated
with an intramuscular injection of 50 mg estrogen and 2 mg
progesterone per day, and Group 5 took an intramuscular in-
jection of androgen (testosterone enanthate, 1.8 mg/day;
Paddock Laboratories, Inc., North Minneapolis, MN, USA).
With regard to hormone levels prior to and after ovariectomy
and after hormonal supplementation, our preliminary data
(unpublished) showed that average estrogen levels in pre-
ovariectomy, postovariectomy, 1 day hormonal treatment, 3
days hormonal treatment, and 7 days hormonal treatment were
55.9 pg/mL,14.6 pg/mL, 147.3 pg/mL, 162.5 pg/mL, and
171.1 pg/mL; average progesterone levels were 14.2 ng/mL,
3.3 ng/mL, 84.3 ng/mL, 118.2 ng/mL, and 122.4 ng/mL; and
average testosterone levels were 0.33 pg/mL, 0.008 pg/mL,
19.6 pg/mL, and 20.5/22.1 pg/mL, respectively.
Every group with 6 rats in each subgroup was given a
different dosage of hormone; the rats underwent analysis of
apoptosis and proliferating cell nuclear antigen (PCNA) after
1 day, 3 days, and 7 days of hormonal supplementation. Each
animal was sacrificed with pentobarbital injection, and the
total urinary bladder was removed and placed in iced balanced
salt solution. For immunohistochemical study, fresh-frozen
bladder sections were used. The dissected bladders were
frozen in powdered dry ice and stored at e70 C. Then, they
were subjected to cryosections (10 mm) at e18 C, with the
sections transferred to glass microscope slides coated with
saline. The sections were air dried for 30 minutes at room
temperature and fixed in 3.7% formaldehyde solution for
10 minutes. All animal experiments were carried out in
accordance with the National Institutes of Health Guide for theCare and Use of Laboratory Animals (NIH Publications No.
80-23, revised 1996).
To detect proliferation, the sections were treated with 3%
hydrogen peroxidase in methanol for 5 minutes at room
temperature and then washed with phosphate buffered saline
buffer. After blocking with 10% normal horse serum for 1 hour
at room temperature, the sections were rinsed and incubated
overnight at 4 C with a mouse monoclonal antibody against
PCNA (PC10, IG2a, DAKO, Glostrup, Demark) diluted in the
buffer (1:500). Then again washed and incubated for 2 hours
with biotinylated anti-mouse IgG made in horse in the buffer
(1:200), followed by incubation for 30 minutes with avi-
dinebiotinehorseradish peroxidase complex. Staining was
developed with diaminobenzidine (DAB) in the presence of
0.03% H2O2. A 1% methyl green solution was used for the
counterstaining (Fig. 1).
To detect apoptotic cells in the detrusor muscle layer of
urinary bladder, the TACS terminal deoxynucleotidyl trans-
ferase (TdT)-DAB In Situ Apoptosis Detection Kit (Trevigen,
Gaithersburg, MD, USA) was applied to perform TdT-mediated
dUTP nick end labeling (TUNEL) staining (Fig. 2). Briefly, the
sections were incubated with proteinase K (20 mg/mL) for
15 minutes at room temperature, washed in distilled water, and
then treated with 3% hydrogen peroxidase in methanol for
5 minutes at room temperature to quench endogenous peroxi-
dase activity. The sections were immersed in TdT labeling
buffer for 5 minutes at room temperature, and then TdT and
biotinylated dNTP in TdT labeling buffer were dropped into the
sections. After incubation at 37 C for 2 hours, they were
transferred into TdT stop buffer for 5 minutes at room tem-
perature, followed by rinsing with phosphate buffered saline
and later treatment with streptavidinehorseradish peroxidase
for 10 minutes at room temperature. Finally, the sections un-
derwent wash with phosphate buffered saline and were then
developed with DAB in the presence of 0.03% H2O2. A 1%
methyl green solution was used for the counterstaining.
The numbers of apoptotic and proliferating cells were
calculated by counting at least 1000 cells per urinary bladder
in 10 randomly chosen field stained nuclei of cells under a
magnification of 400 [14]. The proliferative index for each
sample was the percentage of cells positive for PCNA. The
apoptotic index was counted in the same fashion as was
described for PCNA-positive cells. The statistics was done by
Student t test or one-way analysis of variance, as appropriate.
A p value <0.05 was considered statistically significant. Data
are presented as the mean  standard error of the mean.
Results
In Fig. 3, when compared to the group of bilateral ovari-
ectomy without hormonal supplementation, the groups given
3 days and 7 days estrogen supplementation demonstrated a
significant improvement of proliferative index ( p ¼ 0.031 and
p ¼ 0.005, respectively). The increase was also significant
in the group given 7 days combined supplementation with
estrogen and progesterone ( p ¼ 0.044). In Fig. 4, according to
the apoptotic index, the apoptosis after castration did not seem
Fig. 1. Proliferating cell nuclear antigen (arrows) immunoreactive cells in the detrusor muscle layer of urinary bladder at (AeE) 3 days and (FeJ) 7 days. Castrated
rats received hormonal supplementation, including (A and F) bilateral ovariectomy without hormonal supplementation, (B and G) estrogen, (C and H) proges-
terone, (D and I) estrogen þ progesterone (E þ P), (E and J) testosterone. Bar indicates 50 mm in A.
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Fig. 2. Apoptotic cells (arrows) in the detrusor muscle layer of urinary bladder. (A) Positive control is generated by TACS-Nuclease treatment prior to TdT la-
beling, 100. (B) Castrated rat without hormonal supplementation, 400. (C) Castrated rat with 7 days estrogen supplementation, 400. BO ¼ bilateral
ovariectomy.
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days to 7 days in all groups except the estrogen supplemen-
tation group; there was a significant decrease in apoptotic
index in the group given 7 days estrogen supplementation
when compared to bilateral ovariectomy without hormonal
supplementation ( p ¼ 0.035).Discussion
The female lower urinary tract is thought to be a target
organ for the action of the sex steroid hormones; however,
studies of estrogen effects on the urethra and the urinary
bladder of animal origin are scarce. Morphological changes in
response to ovariectomy and estrogen replacement had been
researched in some studies [5e9,15]. The urothelium was
reported so sensitive to changes in circulating estradiol that
ovariectomy could induce significant urothelial atrophy [7,8].
In previous reports, histologically, ovariectomy resulted in
significant urothelial apoptosis, which did not happen to
the sham-operated or estradiol-treated mice [10]. AlthoughFig. 3. Change in the proliferative indices of ovariectomized rats in response to
sex steroid hormones. + Difference from BO group is statistically significant at
p < 0.05; ++ Difference from BO group is statistically significant at
p < 0.001. BO ¼ bilateral ovariectomy; E þ P ¼ estrogen þ progesterone.apoptosis in the urethra and rhabdosphincter has been inves-
tigated [16], employing TUNEL method for detecting
apoptosis in detrusor muscle has been discussed in only one
study to date; Smeulders et al [17] analyzed detrusor muscle
differentiation in normal mice with a focus on cell prolifera-
tion and apoptosis. Their results showed that PCNA expression
in the detrusor was the highest at organ inception and fell
stepwise at each developmental stage with low levels post-
natally and apoptosis in the detrusor was only detected on
embryonic Day 14.
Based on the observation of Aikawa et al [10] that ovari-
ectomy in rabbits resulted in a 50% decrease in circulating
estradiol at 2 weeks and maintained the similar estradiol
concentration until 6 weeks after castration, we chose 2 weeks
following ovariectomy as the optimal timing to assess the
expression of apoptosis in detrusor muscle using the TUNEL
method in this study. Our data demonstrate that the increased
apoptosis observed in the bladders of rats that were ovariec-
tomized without estrogen replacement was evidence enough of
a quantitative structural change related to estrogen deprivation.
We found a significant decrease of apoptotic index in theFig. 4. Change in the apoptotic indices of ovariectomized rats in response to
sex steroid hormones. + Difference from BO group is statistically significant at
p < 0.05. BO ¼ bilateral ovariectomy; E þ P ¼ estrogen þ progesterone.
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ovariectomized group. The alterations of apoptotic indices in
this study support that cell apoptosis in the detrusor muscle
was at least in part mediated by estrogen.
Ovariectomy and estrogen treatment resulted in morpho-
logic changes within the rodent urinary bladder that correlated
with the bladder smooth muscle cell density [3,8], but whether
estrogen may increase bladder smooth muscle cells still re-
mains unclear. Our study provides useful information at
cellular level by delineating the mechanism for the morpho-
logical change of increase of bladder mass after estrogen
treatment arising from proliferation of bladder smooth muscle
cells. Blakeman et al [18] assessed the expression of Ki-67
antigen [19], a marker of cell proliferation, in the epithelial,
subepithelial, and muscle or deep fascial regions of the female
lower urinary tract; they found that squamous epithelia of the
female lower urinary tract exhibited greater levels of cell
proliferation in estrogen-replete as compared with estrogen-
deficient women [18]. In the current study, the estrogen ef-
fect on cell proliferation in detrusor muscle was studied by the
expression of PCNA, which has been shown to be a nuclear
protein for DNA polymerase delta associated with completing
a cell cycle [20]. Our results demonstrate that the proliferative
indices had a significant increase in the ovariectomized rats
after 3 days and 7 days of estrogen supplementation, sup-
porting the role of estrogen as a stimulator of cell prolifera-
tion. However, such a stimulator action of estrogen could be
inhibited by progesterone in tissues of genitourinary tract
[8,11]. As reported previously, progesterone could down-
regulate estrogen receptors in the endometrium and therefore
prevent endometrial hyperplastic changes of endometrium [8].
Progesterone may also exert an effect on the lower urinary
tract either by inhibiting estrogen action, or by a direct effect
on progesterone receptors [11]. The findings of progesterone
receptor in the suburethral tissues, which also contain the
innervation to the detrusor muscle, support a potential role for
a direct effect of progesterone on detrusor muscle [11]. In our
study, exogenous progesterone alone had no influence in
bladder detrusor muscle in cell proliferation. Although the
proliferative index showed an increase in the ovariectomized
rats receiving 7 days combined supplementation of estrogen
and progesterone, we thought the significant increase was
caused by estrogen effect. Hashimoto et al [8] revealed similar
results that estrogen replacement therapy possibly increased
the number of smooth muscle cells in the ovariectomized
rabbit’s bladder and combined treatment by progesterone did
not significantly lessen this effect.
So far, the mechanism by which estrogen may inhibit
apoptosis but increase proliferation of the urinary bladder
muscle is not yet understood. One hypothesis stated that es-
trogen controlled bladder and mucosal morphology and
function in part by acting as a growth factor, thus, regulating
cellular growth and division [10]. Aikawa et al [10] speculated
that estradiol administration results in increases in smooth
muscle density of the bladder through the action of stimulating
specific growth factors, such as fibroblast growth factor, basic
fibroblast growth factor, and transforming growth factor-b. Insupport of this idea is a study demonstrating that local syn-
thesis of basic fibroblast growth factor and transforming
growth factor-b may be responsible for initiating cell hyper-
plasia and apoptosis that mediates the bladder’s response to
transient urethral obstruction [21]. Prior studies reveal that the
influence of estrogen on bladder function was determined by
estrogen receptor density [3]. Therefore, quantifying the levels
of sex hormone receptors in the urinary bladder muscle is
helpful in delineating the relationship between estrogen
treatment and the expression of various sex hormone receptors
in detrusor smooth muscle of ovariectomized rats [22]. In the
present study we mainly focused on the processes of tissue
growth and remodeling, the effects of sex hormones on cell
apoptosis and proliferation in the detrusor muscle. Thus, future
research needs to be conducted to better understand the
expression of protein and mRNA of sex hormone receptors in
the urinary bladder muscle prior to and after ovariectomy and
medication.
In conclusion, our experiment showed that exogenous es-
trogen supplementation stimulates proliferation and slows
down apoptosis in the detrusor muscle of ovariectomized rat
urinary bladder and its effect in proliferation is not offset by
concomitant use of progesterone. Neither exogenous proges-
terone nor testosterone are noted for their influence in detrusor
muscle in both cell proliferation and apoptosis. Our results
may have clinical implications for estrogen supplementation in
offering benefits to menopausal women with lower urinary
tract syndromes, based on evaluating the relation between cell
apoptosis and cell proliferation.Acknowledgments
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